Objective: The increasing use of imaging examinations such as computed tomography (CT) results in increased contrast media use, which increases contrast media-induced adverse reactions (AR). This study investigated the risk factors of ARs to nonionic iodinated contrast media. Methods: This study eva...
Objective: The increasing use of imaging examinations such as computed tomography (CT) results in increased contrast media use, which increases contrast media-induced adverse reactions (AR). This study investigated the risk factors of ARs to nonionic iodinated contrast media. Methods: This study evaluated patients who were administered iodinated contrast media during CT scanning in Yeouido St. Mary's Hospital in Seoul, Korea in 2012. Among the subjects, those with contrast media-induced ARs were classified as the AR group. The control group included individuals without ARs who were selected through simple random sampling. The effects of sex, age, contrast media type and dose, CT region, previous contrast media administration, allergy history, and comorbidity were analyzed in the AR and control groups. Results: Multivariate logistic regression analyses were performed to evaluate the identified AR risk factors in 103 subjects in the AR group and 412 subjects in the control group. The results confirmed that the risk of developing ARs was significantly higher in females [odds ratio (OR): 2.206; 95% confidence interval (CI): 1.353-3.598], in individuals administered Iohexol (OR: 9.981; 95% CI: 2.361-42.193), in individuals with an allergy history (OR: 3.982; 95% CI: 1.742-9.101), and in individuals with comorbid asthma (OR: 6.619; 95% CI: 1.377-31.826). Most of the ARs were mild and immediate. Conclusion: In patients who were administered contrast media during CT scans, female gender, Iohexol use, allergy history, and asthma were risk factors for ARs. Therefore, special care is required for patients with such risk factors to prevent ARs.
Objective: The increasing use of imaging examinations such as computed tomography (CT) results in increased contrast media use, which increases contrast media-induced adverse reactions (AR). This study investigated the risk factors of ARs to nonionic iodinated contrast media. Methods: This study evaluated patients who were administered iodinated contrast media during CT scanning in Yeouido St. Mary's Hospital in Seoul, Korea in 2012. Among the subjects, those with contrast media-induced ARs were classified as the AR group. The control group included individuals without ARs who were selected through simple random sampling. The effects of sex, age, contrast media type and dose, CT region, previous contrast media administration, allergy history, and comorbidity were analyzed in the AR and control groups. Results: Multivariate logistic regression analyses were performed to evaluate the identified AR risk factors in 103 subjects in the AR group and 412 subjects in the control group. The results confirmed that the risk of developing ARs was significantly higher in females [odds ratio (OR): 2.206; 95% confidence interval (CI): 1.353-3.598], in individuals administered Iohexol (OR: 9.981; 95% CI: 2.361-42.193), in individuals with an allergy history (OR: 3.982; 95% CI: 1.742-9.101), and in individuals with comorbid asthma (OR: 6.619; 95% CI: 1.377-31.826). Most of the ARs were mild and immediate. Conclusion: In patients who were administered contrast media during CT scans, female gender, Iohexol use, allergy history, and asthma were risk factors for ARs. Therefore, special care is required for patients with such risk factors to prevent ARs.
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
문제 정의
Therefore, the objectives of this study were to identify the risk factors for adverse reactions in Korean patients who were administered iodinated contrast media during CT scans through a retrospective prescription analysis and electronic medical record investigation and to analyze the frequency of adverse reaction occurrences.
가설 설정
2) It was performed in a single medical center on a relatively small number of patients.
제안 방법
Frequency analyses and basic statistical analyses were performed to analyze the general characteristics of the subjects. For both the AR group and the control group, continuous variables, including age and dose, were presented as the mean and standard deviation (SD), and t-tests were performed.
The characteristics of the subjects who underwent kidney CT scans were exactly the same as those who were administered the contrast medium Iohexol and they were therefore excluded from multivariate logistic regression analysis.
The subjects who experienced contrast media-induced adverse reactions were classified into the adverse reaction (AR) group. The control group was populated by selecting 4 times as many subjects as the number of patients in the AR group out of a group of patients without adverse reactions using simple random sampling. The electronic medical records of the patients of the AR and control groups were examined to investigate previous contrast media administration, allergy history, comorbidity, and contrast media-induced adverse reactions, which ultimately enabled the identification of risk factors for contrast media-induced adverse reactions and the analysis of the frequency of adverse reaction occurrences.
The control group was populated by selecting 4 times as many subjects as the number of patients in the AR group out of a group of patients without adverse reactions using simple random sampling. The electronic medical records of the patients of the AR and control groups were examined to investigate previous contrast media administration, allergy history, comorbidity, and contrast media-induced adverse reactions, which ultimately enabled the identification of risk factors for contrast media-induced adverse reactions and the analysis of the frequency of adverse reaction occurrences.
The other categorical variables were subjected to cross tabulation analyses with Chi-square tests and Fisher's exact tests.
대상 데이터
Mary’s Hospital IRB Committee. Adult patients aged 18 years or older who were administered iodinated contrast media during CT scans between January 1 and December 31, 2012, were included. Patients were excluded if they had no follow-up or lacked electronic medical records.
In this study, patients were administered various types of iodinated contrast media, including iohexol, iomeprol, ioversol, iopromide, and iodixanol. Iohexol, iomeprol, ioversol, and iopromide are nonionic, monomeric, low osmolar contrast media, while iodixanol is a nonionic, dimeric, iso-osmolar contrast medium.
Of the 17,408 subjects who underwent CT scans with iodinated contrast media during the study period, adverse reactions were reported in 103 subjects (0.6%).
During the study period, the total number of subjects who were administered iodinated contrast media while undergoing CT scans was 17,408. The AR group, which included individuals who experienced contrast media-induced adverse reactions, included 103 subjects, and the control group, which was designed to have 4 times as many subjects as the AR group, included 412 subjects.
This study evaluated patients who were administered iodinated contrast media during CT scans at Yeoeuido St. Mary’s Hospital, a tertiary teaching hospital in Seoul, Korea, from January to December 2012.
데이터처리
Frequency analyses and basic statistical analyses were performed to analyze the general characteristics of the subjects. For both the AR group and the control group, continuous variables, including age and dose, were presented as the mean and standard deviation (SD), and t-tests were performed. The other categorical variables were subjected to cross tabulation analyses with Chi-square tests and Fisher's exact tests.
성능/효과
Among the included patient factors, females [odds ratio (OR): 2.091; 95% confidence interval (CI): 1.345-3.252], allergy history (OR: 2.707; 95% CI: 1.274-5.752), and comorbid asthma (OR: 5.203; 95% CI: 1.372-19.735) were confirmed as significant variables that increase the risk of contrast media-induced adverse reactions.
In the results, immediate adverse reactions that occurred within 1 hour of contrast media administration were identified in 96 subjects (93.2%), which accounts for the majority of the adverse reactions. Such results showing that most contrast media-induced adverse reactions are immediate adverse reactions are in agreement with previous studies.
0 g (mean ± SD). Regarding CT region, in cases where the same patient underwent CT scans of different regions, each region was calculated separately, and the results showed that the abdomen (pelvis) was the most commonly scanned region with 3,856 subjects (22.2%), followed by the chest with 3,416 subjects (19.6%), and the liver/spleen/pancreas with 3,199 subjects (18.4%) (Table 1).
Regarding contrast media factors, using Iohexol as a contrast medium (OR: 11.995; 95% CI: 4.067-35.379) and scanning the kidney during CT (OR: 3.191; 95% CI: 1.307-7.795) were confirmed to be significant variables that increased the risk of adverse reactions, whereas scanning the abdomen (pelvis) during CT (OR: 0.447; 95% CI: 0.229-0.872) was confirmed as a significant variable that decreased the risk of adverse reactions.
There was a statistically significant difference in the types of contrast media used between the AR group and the control group. The percentage of CT scans of the kidney was significantly higher in the AR group than in the control group, whereas the percentage of scans of the abdomen (pelvis) was significantly lower (Table 3).
193). The presence of an allergy history was associated with a 3.982-fold higher risk of adverse reactions compared to the absence of one (OR:3.982; 95% CI: 1.742-9.101), and the presence of asthma as comorbidity led to a 6.619-fold higher AR risk (OR: 6.619;95% CI: 1.377-31.826) (Table 4).
This study found that female sex, the use of Iohexol as a contrast medium, an allergy history, and comorbid asthma were risk factors for contrast media-induced adverse reactions. For safe contrast media utilization, evaluations of whether an individual patient possesses risk factors for contrast mediainduced adverse reactions should be performed prior to contrast media administration.
참고문헌 (18)
Ono K, Yoshitake T, Hasegawa T, et al. Estimation of the number of CT procedures based on a nationwide survey in Japan. Health Phys 2011; 100:491-6.
Berrington de Gonzalez A, Mahesh M, Kim KP, et al. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med 2009;169:2071-7.
Gomi T, Nagamoto M, Hasegawa M, et al. Are there any differences in acute adverse reactions among five low-osmolar non-ionic iodinated contrast media? Eur Radiol 2010;20:1631-5.
Katayama H, Yamaguchi K, Kozuka T, et al. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 1990;175:621-8.
Sutton AG, Finn P, Grech ED, et al. Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterization. Am Heart J 2001;141:677-83.
Lasser EC, Lyon SG, Berry CC. Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration. Radiology 1997;203:605-10.
Mortele KJ, Oliva MR, Ondategui S, et al. Universal use of nonionic iodinated contrast medium for CT: evaluation of safety in a large urban teaching hospital. AJR Am J Roentgenol 2005;184:31-4.
Bush WH, Swanson DP. Acute reactions to intravascular contrast media: types, risk factors, recognition, and specific treatment. AJR Am J Roentgenol 1991;157:1153-61.
Brockow K, Ring J. Classification and pathophysiology of radiocontrast media hypersensitivity. Chem Immunol Allergy 2010;95:157-69.
Kobayashi D, Takahashi O, Ueda T, et al. Risk factors for adverse reactions from contrast agents for computed tomography. BMC Med Inform Decis Mak 2013;13:18.
Traub SJ, Kellum JA, Tang A, et al. Risk factors for radiocontrast nephropathy after emergency department contrast-enhanced computerized tomography. Acad Emerg Med 2013;20:40-5.
Zhang BC, Hou L, Lv B, et al. Post-marketing surveillance study with iodixanol in 20 185 Chinese patients from routine clinical practices. Br J Radiol 2014;87:20130325.
American College of Radiology. ACR manual on contrast media, version 9, 2013. Available from http://www.acr.org/Quality-Safety/Resources/Contrast-Manual. Accessed October 25, 2015.
Solomon R. The role of osmolality in the incidence of contrast-induced nephropathy: a systematic review of angiographic contrast media in high risk patients. Kidney Int 2005;68:2256-63.
Wendt-Nordahl G, Rotert H, Trojan L, et al. Intravenous contrast media in uroradiology: evaluation of safety and tolerability in almost 50,000 patients. Med Princ Pract 2006;15:358-61.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.